Atwood & Palmer’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44.2M | Buy |
350,240
+2,801
| +0.8% | +$369K | 2.36% | 13 |
|
|
2026
Q1 | $48.4M | Sell |
347,439
-2,396
| -0.7% | -$336K | 2.73% | 8 |
|
|
2025
Q4 | $42.9M | Buy |
349,835
+5,685
| +2% | +$691K | 2.44% | 11 |
|
|
2025
Q3 | $38.2M | Buy |
344,150
+68
| +0% | +$7.73K | 2.24% | 13 |
|
|
2025
Q2 | $38.1M | Sell |
344,082
-985
| -0.3% | -$105K | 2.38% | 12 |
|
|
2025
Q1 | $38.7M | Sell |
345,067
-4,189
| -1% | -$432K | 2.68% | 6 |
|
|
2024
Q4 | $32.3M | Buy |
349,256
+2,576
| +0.7% | +$232K | 2.21% | 15 |
|
|
2024
Q3 | $29.1M | Buy |
346,680
+736
| +0.2% | +$56.2K | 1.98% | 19 |
|
|
2024
Q2 | $23.7M | Sell |
345,944
-850
| -0.2% | -$56.7K | 1.8% | 24 |
|
|
2024
Q1 | $25.4M | Buy |
346,794
+8,375
| +2% | +$644K | 1.93% | 21 |
|
|
2023
Q4 | $27.4M | Buy |
338,419
+475
| +0.1% | +$37K | 2.22% | 16 |
|
|
2023
Q3 | $25.3M | Buy |
337,944
+1,195
| +0.4% | +$91.9K | 2.22% | 18 |
|
|
2023
Q2 | $26M | Buy |
336,749
+89,479
| +36% | +$7.14M | 2.32% | 15 |
|
|
2023
Q1 | $20.5M | Buy |
247,270
+244
| +0.1% | +$20.2K | 1.93% | 20 |
|
|
2022
Q4 | $21.2M | Buy |
247,026
+4,390
| +2% | +$348K | 1.92% | 17 |
|
|
2022
Q3 | $15M | Buy |
242,636
+5,506
| +2% | +$347K | 1.48% | 26 |
|
|
2022
Q2 | $14.7M | Buy |
237,130
+4,387
| +2% | +$272K | 1.43% | 30 |
|
|
2022
Q1 | $13.8M | Buy |
232,743
+4,605
| +2% | +$294K | 1.19% | 36 |
|
|
2021
Q4 | $16.6M | Buy |
228,138
+10,196
| +5% | +$702K | 1.39% | 31 |
|
|
2021
Q3 | $15.2M | Buy |
217,942
+3,300
| +2% | +$232K | 1.36% | 32 |
|
|
2021
Q2 | $14.8M | Buy |
214,642
+6,338
| +3% | +$423K | 1.33% | 32 |
|
|
2021
Q1 | $13.5M | Buy |
208,304
+1,293
| +0.6% | +$83.4K | 1.3% | 32 |
|
|
2020
Q4 | $12.1M | Buy |
207,011
+1,897
| +0.9% | +$114K | 1.29% | 31 |
|
|
2020
Q3 | $13M | Sell |
205,114
-422
| -0.2% | -$29.3K | 1.63% | 25 |
|
|
2020
Q2 | $15.8M | Sell |
205,536
-3,473
| -2% | -$266K | 2.14% | 20 |
|
|
2020
Q1 | $15.6M | Buy |
209,009
+1
| +0% | +$69 | 2.45% | 14 |
|
|
2019
Q4 | $13.6M | Sell |
209,008
-9,731
| -4% | -$634K | 1.75% | 23 |
|
|
2019
Q3 | $13.9M | Sell |
218,739
-2,114
| -1% | -$138K | 1.87% | 23 |
|
|
2019
Q2 | $14.9M | Buy |
220,853
+282
| +0.1% | +$18.6K | 2.02% | 20 |
|
|
2019
Q1 | $14.3M | Buy |
220,571
+257
| +0.1% | +$17.1K | 2.03% | 19 |
|
|
2018
Q4 | $13.8M | Sell |
220,314
-694
| -0.3% | -$48.5K | 2.19% | 18 |
|
|
2018
Q3 | $17.1M | Buy |
221,008
+652
| +0.3% | +$49.2K | 2.23% | 18 |
|
|
2018
Q2 | $15.6M | Sell |
220,356
-4,032
| -2% | -$285K | 2.14% | 16 |
|
|
2018
Q1 | $16.9M | Sell |
224,388
-2,390
| -1% | -$190K | 2.41% | 15 |
|
|
2017
Q4 | $16.2M | Sell |
226,778
-490
| -0.2% | -$37.2K | 2.28% | 18 |
|
|
2017
Q3 | $18.4M | Sell |
227,268
-2,274
| -1% | -$174K | 2.67% | 16 |
|
|
2017
Q2 | $16.2M | Buy |
229,542
+3,442
| +2% | +$229K | 2.55% | 19 |
|
|
2017
Q1 | $15.4M | Sell |
226,100
-6,919
| -3% | -$487K | 2.45% | 19 |
|
|
2016
Q4 | $16.7M | Sell |
233,019
-2,606
| -1% | -$194K | 3% | 12 |
|
|
2016
Q3 | $18.6M | Sell |
235,625
-2,023
| -0.9% | -$164K | 3.39% | 7 |
|
|
2016
Q2 | $19.8M | Buy |
237,648
+1,172
| +0.5% | +$104K | 3.58% | 6 |
|
|
2016
Q1 | $21.7M | Buy |
236,476
+55,826
| +31% | +$5.03M | 3.86% | 3 |
|
|
2015
Q4 | $18.3M | Buy |
180,650
+3,901
| +2% | +$406K | 3.47% | 4 |
|
|
2015
Q3 | $17.4M | Buy |
176,749
+11,136
| +7% | +$1.24M | 3.39% | 3 |
|
|
2015
Q2 | $19.4M | Buy |
165,613
+226
| +0.1% | +$24.7K | 3.49% | 3 |
|
|
2015
Q1 | $16.2M | Sell |
165,387
-320
| -0.2% | -$32.5K | 2.9% | 5 |
|
|
2014
Q4 | $15.6M | Sell |
165,707
-6,125
| -4% | -$633K | 2.92% | 6 |
|
|
2014
Q3 | $18.3M | Buy |
171,832
+45,944
| +36% | +$4.5M | 3.45% | 4 |
|
|
2014
Q2 | $10.4M | Sell |
125,888
-48,539
| -28% | -$3.78M | 2.78% | 4 |
|
|
2014
Q1 | $12.4M | Buy |
174,427
+3,643
| +2% | +$286K | 2.89% | 9 |
|
|
2013
Q4 | $12.8M | Buy |
170,784
+750
| +0.4% | +$52.2K | 3.16% | 10 |
|
|
2013
Q3 | $10.7M | Buy |
170,034
+1,130
| +0.7% | +$67.5K | 2.95% | 13 |
|
|
2013
Q2 | $8.66M | Buy |
+168,904
| New | +$8.8M | 2.34% | 15 |
|
Other funds holding GILD
Atwood & Palmer's GILD Position: Q2 2026 in Review
Atwood & Palmer increased its Gilead Sciences (GILD) stake by 0.81% in Q2 2026, buying an estimated $369K and bringing the position to 350,240 shares worth $44.2M. The position accounts for 2.36% of the portfolio, ranked #13.
Atwood & Palmer first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $48.4M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Atwood & Palmer held 350,240 shares of Gilead Sciences worth $44.2M as of Q2 2026.
- Atwood & Palmer bought 2,801 Gilead Sciences shares in Q2 2026, an estimated $369K.
- Gilead Sciences made up 2.36% of Atwood & Palmer's portfolio in Q2 2026, its #13 holding.
- Atwood & Palmer first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Atwood & Palmer's Gilead Sciences position peaked at $48.4M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.